Showing results (81-90 of 782) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|January 9, 2020
Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trialDirk Schürmann, Deanne Jackson Rudd, Saijuan Zhang, et al.
The Lancet. HIV|December 4, 2018
Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case reportStephanie E Cohen, Darpun Sachdev, Sulggi A Lee, et al.
The Lancet. HIV|September 27, 2025
ART-free HIV-1 remission in children with in-utero HIV-1 after very early ART (IMPAACT P1115): a multicentre, open-label, phase 1/2 proof-of-concept studyDeborah Persaud, Anne Coletti, Bryan S Nelson, et al.
The Lancet. HIV|June 29, 2025
Oral antiretroviral adherence interventions in the era of U=UClaire M Keene, Lora L Sabin, Lauren Jennings, et al.
The Lancet. HIV|July 5, 2025
Progress in the HIV response in Uganda: findings from two sequential population-based HIV impact assessment surveys, 2017-21Mansoor Farahani, Wilford L Kirungi, Shannon M Farley, et al.
The Lancet. HIV|July 4, 2025
Safety and immunogenicity of investigational tuberculosis vaccine M72/AS01E-4 in people living with HIV in South Africa: an observer-blinded, randomised, controlled, phase 2 trialAlemnew F Dagnew, Linda L Han, Kogieleum Naidoo, et al.
The Lancet. HIV|May 12, 2025
The global HIV response at a crossroads: protecting gains and advancing sustainability amid funding disruptionsBeatrice Matanje, Ruth Laibon Masha, Gallican Rwibasira, et al.
The Lancet. HIV|May 3, 2025
The future of HIV diagnostics: an exemplar in infectious diseasesNitika Pant Pai, Rigveda Kadam, Ilesh Jani, et al.
The Lancet. HIV|March 29, 2025
Causes of hospitalisation among people living with HIV worldwide, 2014-23: a systematic review and meta-analysisRachael M Burke, Nadia Sabet, Jayne Ellis, et al.
The Lancet. HIV|March 30, 2025
The Situated Vulnerabilities and Resiliencies Framework: a call for integrated strategies to address global HIV inequities for transgender, non-binary, and gender diverse populationsSari L Reisner
Pageof 79